Markets:

Overview

News

Currencies

International

Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

100.66 +0.40 (+0.40%)

Streaming Delayed Price Updated: 3:29 PM EDT, Aug 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

24 25 Next >

Lantheus Earnings: What To Look For From LNTH

May 06, 2025

Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be announcing earnings results tomorrow before market open. Here’s what you need to know.

Via StockStory

8 Health Care Stocks Whale Activity In Today's Session ↗

May 01, 2025

Via Benzinga

Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies

April 30, 2025

Company plans to file NDA in the third quarter of this year

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus' Pylarify Hit $1B in 2024 Sales ↗

February 27, 2025

Via The Motley Fool

Earnings Scheduled For February 26, 2025 ↗

February 26, 2025

Via Benzinga

Lantheus (LNTH): A 10x Opportunity in Radiopharmaceuticals ↗

February 25, 2025

Via The Motley Fool

In the world of growth stocks, LANTHEUS HOLDINGS INC (NASDAQ:LNTH) shines as a value proposition. ↗

April 29, 2025

LANTHEUS HOLDINGS INC could be undervalued. NASDAQ:LNTH is scoring impressively in terms of growth while demonstrating strong financials. On top of that, it remains attractively priced.

Via Chartmill

Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time

April 23, 2025

From Lantheus Holdings, Inc.

Via GlobeNewswire

Q4 Earnings Outperformers: Hologic (NASDAQ:HOLX) And The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks

April 10, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices & supplies - imaging, diagnostics stocks...

Via StockStory

Topics Artificial Intelligence

LANTHEUS HOLDINGS INC (NASDAQ:LNTH), a growth stock which is not overvalued. ↗

April 07, 2025

Discover LANTHEUS HOLDINGS INC, an undervalued growth gem. NASDAQ:LNTH is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing...

Via Chartmill

3 Market-Beating Stocks to Consider Right Now

April 07, 2025

Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the...

Via StockStory

Medical Devices & Supplies - Imaging, Diagnostics Stocks Q4 In Review: QuidelOrtho (NASDAQ:QDEL) Vs Peers

April 04, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - imaging, diagnostics industry, including QuidelOrtho (NASDAQ:QDEL) and its...

Via StockStory

Topics Artificial Intelligence

Lantheus Completes Acquisition of Evergreen Theragnostics

April 01, 2025

From Lantheus Holdings, Inc.

Via GlobeNewswire

Q4 Earnings Review: Medical Devices & Supplies - Imaging, Diagnostics Stocks Led by GE HealthCare (NASDAQ:GEHC)

March 31, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at GE HealthCare (NASDAQ:GEHC) and its peers.

Via StockStory

Topics Artificial Intelligence

1 Healthcare Stock on Our Watchlist and 2 to Brush Off

March 21, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID...

Via StockStory

Topics Stocks

For those who appreciate growth without the sticker shock, LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is worth considering. ↗

March 15, 2025

Via Chartmill

Q4 Earnings Highs And Lows: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks

March 10, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - imaging, diagnostics industry, including Lantheus (NASDAQ:LNTH) and its...

Via StockStory

Topics Artificial Intelligence

ResMed Among Top Stocks For Recent And Long-Term Profit Growth ↗

March 10, 2025

A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue?

Via Investor's Business Daily

3 Growth Stocks to Stash

March 07, 2025

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s...

Via StockStory

Root And ZoomInfo Are Among Top 8 Mid-Cap Gainers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio? ↗

March 02, 2025

Top mid-cap stock gainers in past week: Root, Bridge Investment Group, Huron Consulting, Medical Properties Trust, ZoomInfo Technologies, Lantheus Holdings, Alignment Healthcare, VSE. Analysts raise...

Via Benzinga

Workday, ACM Research, ZoomInfo Technologies, CEVA, Intuit And Other Big Stocks Moving Higher On Wednesday ↗

February 26, 2025

Via Benzinga

Lantheus (LNTH) Shares Skyrocket, What You Need To Know

February 26, 2025

Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) jumped 19.8% in the morning session after the company delivered strong fourth-quarter 2024 results, with revenue and earnings...

Via StockStory

Lantheus’s (NASDAQ:LNTH) Q4 Sales Top Estimates, Stock Soars

February 26, 2025

Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 10.5% year on year to $391.1 million. On the other hand,...

Via StockStory

Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance

February 26, 2025

From Lantheus Holdings, Inc.

Via GlobeNewswire

Earnings To Watch: Lantheus (LNTH) Reports Q4 Results Tomorrow

February 25, 2025

Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting earnings tomorrow before market hours. Here’s what you need to know.

Via StockStory

NASDAQ:LNTH is not too expensive for the growth it is showing. ↗

February 21, 2025

LANTHEUS HOLDINGS INC was identified as a growth stock that isn't overvalued. NASDAQ:LNTH is excelling in various growth indicators while maintaining a solid financial footing.

Via Chartmill

Lantheus to Present at Upcoming Investor Conferences

February 21, 2025

From Lantheus Holdings, Inc.

Via GlobeNewswire

Despite its impressive fundamentals, NASDAQ:LNTH remains undervalued. ↗

February 21, 2025

Uncover the potential of LANTHEUS HOLDINGS INC, an undervalued stock. NASDAQ:LNTH maintains a strong financial position and offers an appealing valuation.

Via Chartmill

Lantheus to Host Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on February 26, 2025, at 8:00 a.m. Eastern Time

February 12, 2025

From Lantheus Holdings, Inc.

Via GlobeNewswire

Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting

February 05, 2025

From Lantheus Holdings, Inc.

Via GlobeNewswire

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

All News about Lantheus Holdings, Inc. - Common Stock

Starting at /week.